Spots Global Cancer Trial Database for perfusion magnetic resonance imaging
Every month we try and update this database with for perfusion magnetic resonance imaging cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | NCT00662506 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Cediranib Malea... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Intensity-Modul... Laboratory Biom... Perfusion Magne... Positron Emissi... Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | NCT02722525 | Cardiovascular ... Prostate Carcin... | Magnetic Resona... Exercise Interv... Perfusion Magne... Exercise Interv... Spectroscopy Laboratory Biom... | - | Ohio State University Comprehensive Cancer Center | |
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body | NCT02201797 | Metastatic Live... | DCE MRI | 18 Years - | Asan Medical Center | |
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy | NCT01991977 | Malignant Gliom... | Diffusion Weigh... Fluorine F 18 F... Intensity-Modul... Perfusion Magne... Positron Emissi... Quality-of-Life... Temozolomide | 18 Years - | Mayo Clinic | |
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
18F-DOPA-PET in Planning Surgery in Patients With Gliomas | NCT02020720 | Malignant Gliom... Recurrent Brain... | Biopsy Computed Tomogr... Diffusion Weigh... Fluorine F 18 F... Laboratory Biom... Perfusion Magne... Positron Emissi... Therapeutic Con... | 7 Years - | Mayo Clinic | |
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | NCT02722525 | Cardiovascular ... Prostate Carcin... | Magnetic Resona... Exercise Interv... Perfusion Magne... Exercise Interv... Spectroscopy Laboratory Biom... | - | Ohio State University Comprehensive Cancer Center | |
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | NCT02526511 | Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... | Arterial Spin L... Dynamic Contras... Dynamic Suscept... Perfusion Magne... | 18 Years - | Rutgers, The State University of New Jersey | |
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | NCT02526511 | Stage I Renal C... Stage II Renal ... Stage III Renal... Stage IV Renal ... | Arterial Spin L... Dynamic Contras... Dynamic Suscept... Perfusion Magne... | 18 Years - | Rutgers, The State University of New Jersey | |
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | NCT00662506 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Cediranib Malea... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Intensity-Modul... Laboratory Biom... Perfusion Magne... Positron Emissi... Temozolomide | 18 Years - | National Cancer Institute (NCI) |